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ABSTRACT
Background/aims To evaluate depression, coping with
disease and stress, and the subjective impression of
distress and/or life events as triggers for recurrences in
HLA-B27-associated anterior uveitis (B27-AU), with
attention to gender-specific characteristics.
Methods 171 patients with a history of B27-AU
responded to a postal survey performed between
January 2006 and April 2008 using standardised
psychological questionnaires: Beck Depression Inventory,
Freiburg Questionnaire on Coping with Illness, and Stress
Coping Inventory.
Results Patients with B27-AU differed from healthy
controls showing more depressive symptoms (Beck
Depression Inventory, 31.6%), applying characteristic
disease coping as well as negative stress coping
strategies. Female B27-AU patients tended to react with
depression and male patients to use negative stress
coping strategies. 57.9% of patients believed that
psychological distress was a trigger for relapses, and
34.5% stated specific life events. Together, this group of
patients achieved higher depression scores and used
more negative disease and stress coping styles than
patients without perception of distress.
Conclusion Patients with B27-AU patients exhibited
significant psychopathology concerning depression and
disease coping. Distress and life events were
subjectively suspected to be a trigger. By imparting
knowledge to the patients on probable development of
depressive moods and the role of stress/life events as
trigger for relapses, as well as offering behaviour therapy
to optimise coping, may help patients to cope better
with B27-AU.
Uveitis associated with the HLA-B27 antigen
(B27-AU) is an acute-onset, painful eye disease
with a relapse risk of up to 74%.1 The treatment
consists of anti-inﬂammatory topical and systemic
therapy as well as pharmacologic cycloplegia for
reduction of pain and prevention of synechiae. At
each recurrence the pain, as well as the deteriora-
tion of visual acuity due to inﬂammation and
impaired accommodation pose a strain for the
patients. Furthermore, they may require sick leave
for several days, lose their ability to perform certain
tasks (ie, reading, working on a computer, driving),
and face a risk of losing their jobs. The fact that
a patient with a history of B27-AU is at permanent
risk for a relapse of disease, associated with pain
and fear of a transient or even persistent loss of
vision, causes omnipresent distress (negative forms
of stress, compared with positive forms of stress
(eustress)) and poses a chronic psychological
burden. For rheumatic diseases in general, as well as
for ankylosing spondylitis in particular, a higher
prevalence of depression has been reported.2 3 In
a pilot study, Franke et al dealt with the psycho-
pathology of patients with various forms of uveitis
and pointed out the importance of evaluating
psychological interventions for rehabilitation.4
However, distress does not only play a role as
a consequence of disease. Psychological stress also
has been discussed as a probable trigger for uveitis,
as patients often report the onset of relapses during
or after periods of increased psychological pressure
causing a negative mood. Speciﬁc life events can
cause such distress and therefore have been inves-
tigated in this context. So far, clinical studies on
uveitis have yielded disparate results.4e14 For other
auto-immune diseases, such as multiple sclerosis or
Behcet’s disease, stressful life events were shown
to represent an aggravating factor, as they resulted
in a signiﬁcant increase in risk of disease
exacerbations.15 16
The aim of the present study was to evaluate the
role of distress as a trigger from the patients’ point
of view, as well as to objectively evaluate the
presence of depressive moods and the strategies
used to cope with disease and stress. We decided to
include only patients with a history of anterior
uveitis associated with the HLA-B27-antigen, to
obtain a large and homogenous patient population.
A further point of interest was to delineate gender-
speciﬁc differences. The results could help to gain
further insight into the psychopathology of B27-AU
and underline the importance of psychological
interventions.
MATERIALS AND METHODS
Patient recruitment
This clinic-based, cross-sectional study was
performed at the Uveitis Unit of the Department of
Ophthalmology, Medical University of Vienna,
from January 2006 to April 2008. A written invi-
tation to participate in the study via a postal survey
was sent once to 381 B27-AU patients who had
been treated at the Uveitis Unit since 1980. A
total of 171 patients (45%) with recent and/or
recurrent history of acute B27-AU responded with
a completed questionnaire and were included in the
study. Patients had to indicate whether an acute
relapse was present or not. The booklet containing
the questionnaire was prefaced by a general invi-
tation letter explaining the scientiﬁc character of
1Department of Ophthalmology,
Medical University Vienna,
Vienna, Austria
2Department of Psychology,
Sigmund Freud University,
Vienna, Austria
3Hogrefe Verlag, Vienna, Austria
4Department of Psychiatry,
Medical University Vienna,
Vienna, Austria
5Department of Pediatric
Psychiatry, Medical University
Vienna, Vienna, Austria
Correspondence to
Professor Talin
Barisani-Asenbauer, Laura Bassi
Centre for Expertise Ocuvac,
Centre for Pathophysiology,
Immunology & Infectiology,
Medical University of Vienna,
Kinderspitalgasse 15, 1090
Wien Austria;
ocuvac@meduniwien.ac.at
Dr S M Maca is currently
working at the Hietzing Hospital,
Vienna, Austria.
Accepted 18 July 2010
Published Online First
22 October 2010
Br J Ophthalmol 2011;95:699e704. doi:10.1136/bjo.2009.174839 699
Clinical science
 o
n
 30 January 2019 by guest. Protected by copyright.
http://bjo.bmj.com/
Br J O
phthalm
ol: first published as 10.1136/bjo.2009.174839 on 22 October 2010. Downloaded from 
the survey and that the participation was voluntary. Patients
were informed that the impact of stress on disease coping in
patients with AU was being studied, and the expressions
‘gender ’, ‘depression’ and ‘trigger ’ were not used. Normative
values were obtained in an ethnicity- and aged-matched control
group of 55 healthy individuals (mean age 45.6610.1 years,
p¼0.1).
The survey consisted of three psychometric instruments,
listed below, as well as questions related to sociodemographic
data (gender, age) and uveitis details (age at onset of uveitis, the
number of recurrences in total and approximately per year, the
approximate duration of attacks and interval since the last
recurrence, coexistence of a B27-associated spondylarthropathy).
Furthermore, patients were questioned on the presence of
psychological factors before an attack. Patients could indicate
speciﬁc live events that subjectively were suspected to be
connected with a relapse.
Psychometric instruments
The Beck Depression Inventory (BDI) is a self-report inventory
for differentiation of a clinically relevant depressive mood.17
Twenty questions document the actual severity of depressive
moods, indicated by a sum score (0e63 points). The sum score
also is allocated to one of three clinically relevant groups: ‘not
depressed’ (0e9 points), ‘minimal depressive mood’ (9 to 19 points),
and ‘clinical relevant depressive mood’ (19e63 points).
Coping was assessed by the Freiburg Questionnaire on Coping
with Illness (FQCI).18 This 35-item questionnaire is used to
calculate ﬁve primary dimensions (subscales): ‘depressive coping’,
‘problem-solving behaviour ’,‘distraction and self-revalorisation’
(encouraging oneself), ‘religiousness/quest for meaning’ (each 5e25
points) and ‘cognitive avoidance/ dissimulation’ (trivialising and
wishful thinking, 3e15 points). A high score in a FQCI subscale
indicates a strong tendency to apply this type of coping
mechanism.
Coping was also assessed by the Stress Coping Inventory
(SCI) questionnaire, which consists of 114 items.19 Item scores
(each 0e4 points) are grouped to calculate 19 subscales that
describe various coping strategies (combination of six item
scores, 0e24 points). Alternatively, the items may also be
classiﬁed into two secondary dimensions, namely ‘negative’ or
‘positive coping’ strategies (0e24 points).
Statistics
The SPSS 16.0 software was used for statistical analysis. For
descriptive analysis, data are expressed as total numbers (n),
percentage relating to group (%) and means6SD. The Kolmo-
goroveSmirnoff test was used to test for standard distribution,
the t test or ManneWhitney U test was used as appropriate.
The cut-off level for statistical signiﬁcance was set at p<0.05; all
tests were performed in a two-tailed manner. In case of multiple
testing within a group (gender comparisons concerning BDI
items, FQCI and SCI), a BonferronieHolm correction for
adjustment of the p value was applied.20
RESULTS
A total of 171 patients with known B27-AU, 64 women and 107
men, returned the questionnaires. The gender distribution was
female:male 1:1.7 (p<0.001, table 1).
Thirteen patients (7.6%) had active recurrence at the time of
answering the questionnaire; there was a B27-associated spon-
dylarthropathy in 75 patients (43.9%). Altogether, the patients
had suffered from approximately 12.9620.1 uveitis relapses
since disease onset, which had been 14.369.6 years ago. More
information concerning uveitis recurrences is given in table 1.
No differences in sociodemographic data were found comparing
patients who responded to the survey with those who did not.
BDI
The mean total score obtained in patients with B27-AU was
signiﬁcantly higher than the value obtained from the control
group (8.767.0 and 4.464.3, respectively, p<0.001, table 2,
ﬁgure 1). Patients with an acute relapse scored even worse
(11.367.7, p¼0.19), the coexistence of an additional spondy-
larthropathy did not affect the score (9.567.6, p¼0.13). Among
the B27-AU patients, 31.6% (n¼54) were above ‘normal range’, as
19.3% were classiﬁed to be in a ‘minimal depressive’ and 12.3% in
a ‘clinical relevant depressive’ mood.
Thirty-six per cent of women and 28.9% of men exhibited
depressive moods (p¼0.34), the mean total sum score was
slightly higher in the female group (table 2). In female and
male B27-AU patients the scores were signiﬁcantly higher than
those of the corresponding healthy comparison groups (table 2,
ﬁgure 1). For the individual test items women suffered more
from ‘loss of libido’ than men (women 2.0061.03, men 1.5760.76;
p¼0.002).
FQCI
B27-AU patients exhibited different patterns from controls for
three of ﬁve coping styles. Both women and men tended
towards ‘cognitive avoidance and dissimulation’ (p<0.001, table 2).
Women in particular seemed to lose the ability for ‘distraction
and self-revalorisation’ (p¼0.030), whereas men tended to apply
a ‘problem-solving behaviour ’ (p¼0.004).
German stress coping inventory
Compared with healthy controls, B27-AU patients reached
higher scores on four of 19 subscales, leading to a statistically
signiﬁcant increase of the secondary dimension negative coping
(table 2, p¼0.005). Splitting these ﬁndings according to gender,
female patients seemed to ‘play down the disease’ less (p¼0.030),
needed more ‘social support’ (mean score was signiﬁcantly higher
than in B27-AU males although it should have been similar),
used less ‘self-medication’ (p¼0.005), but reacted with more
‘rumination’ (p¼0.020) than healthy controls. Male patients also
tended to use ‘rumination’ (p¼0.003), but in addition exhibited
aggravated patterns in eight more subscales, displayed in table 2.
Summarised, these patterns are reﬂected in an elevated score of
‘negative coping’ in men (p¼0.002).
Table 1 Patient characteristics for sociodemographics and history of
HLA-B27-associated anterior uveitis (B27-AU)
Total patient
population Women Men
Number of patients (n (%)) 171 64 (37.4) 107 (62.6)y
Current age (years6SD) 48.8 (14.1) 46.6 (14.9) 50.2 (13.4)
Age at onset of uveitis (years6SD) 34.5 (12.6) 33.0 (11.4) 35.5 (13.3)
Uveitis relapses*
Total numbers (n6SD) 12.9 (20.1) 12.6 (18.6) 13.2 (21.0)
Approximate relapses per year (n6SD) 2.5 (1.9) 2.9 (1.9) 2.3 (1.9)
Duration (weeks6SD) 4.9 (4.1) 5.5 (5.0) 4.6 (3.4)
Acute B27-AU at time of study
participation (n (%))
13 (7.6) 5 (7.8) 8 (7.5)
HLA-B27-associated spondylarthropathy
(n (%))
78 (45.6) 27 (42.2) 51 (47.7)
Data are given as total numbers or means; SD or percentage relating to groups is given in
parentheses.
*As subjectively reported by patients.
ySignificance at p<0.05.
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Distress and/or life events as triggers for B27-AU relapses
Many patients (57.9%) (n¼99, p<0.001) had the impression
that psychological factors had an inﬂuence in the sense of trig-
gering B27-AU, and this occurred more often in women than in
men (p¼0.045, ﬁgure 2). Some patients (34.5%) could even state
speciﬁc life events after which an attack had occurred (table 3).
Patients who had mentioned psychological stress with or
without a life event (‘distress’ group) exhibited raised and
depressive BDI sum scores (distress 10.167.9, no distress
7.165.4; p¼0.008). The same ﬁnding was true when assessing
only women (p¼0.042) or men (p¼0.056). These patients also
reached higher scores for depressive coping on the FQCI (distress
11.464.3, no distress 9.763.9; p<0.001), independent of gender
(women 11.663.7, men 11.564.8; p¼0.961). On the SCI
a difference was found for three of the 19 subscales (more
resignation, more rumination, less playing down the disease; all
p<0.001), together resulting in an elevated score of negative
coping (distress 10.964.4, no distress 8.363.6; p<0.001).
DISCUSSION
From the 1960s onwards a number of studies have discussed
a connection between distress or depressive tendencies and
uveitis (table 4).4e14
Nevertheless, these studies draw opposite conclusions. Various
uveitis entities being grouped together, small sample sizes and
Table 2 Results of statistical significance as obtained by the Beck
Depression Inventory (BDI), Freiburg Questionnaire of Coping with Illness
(FQCI) and Stress Coping Inventory (SCI) in patients with HLA-B27-
associated anterior uveitis (B27-AU) and an age-matched, healthy
control group
Patients (P)
vs controls (C) Total Women Men
p Value
for gender
differences
Numbers P 171 64 107
C 55 33 22
BDI sum score P 8.7 (7.0) 9.5 (7.6) 8.4 (6.7) n.s.
C 4.4 (4.3) 4.5 (4.0) 4.1 (4.7) n.s.
p<0.001* p¼0.004* p¼0.02*
FQCI
Problem-solving
behaviour
P 16.2 (4.7) 16.5 (5.2) 16.1 (4.4) n.s.
C 14.1 (3.7) 14.9 (2.9) 13.0 (4.4) n.s.
p¼0.004* n.s. p¼0.004*
Distraction and
self-revalorisation
P 15.2 (4.2) 15.7 (4.4) 14.9 (4.0) n.s.
C 16.7 (3.7) 17.6 (3.1) 15.5 (4.3) n.s.
n.s. p¼0.030* n.s.
Cognitive
avoidance and
dissimulation
P 6.6 (2.8) 7.0 (3.1) 6.4 (2.6) n.s.
C 4.5 (1.9) 4.3 (1.5) 4.7 (2.4) n.s.
p<0.001* p<0.001* p¼0.005*
SCI
Playing down
the disease
P 10.6 (4.7) 9.4 (4.6) 11.3 (4.7) n.s.
C 12.3 (4.3) 10.7 (4.2) 13.0 (4.6) n.s.
p¼0.02* p¼0.030* n.s.
Substitutional
satisfaction
P 10.2 (5.7) 12.0 (5.2) 9.0 (5.7) p¼0.002y
C 11.0 (4.4) 12.4 (4.3) 9.4 (4.1) p<0.001y
n.s. n.s. n.s.
Attempt to
control reactions
P 14.6 (4.4) 14.3 (4.5) 14.8 (4.3) n.s.
C 13.4 (3.8) 14.4 (3.4) 13.0 (4.7) n.s.
n.s. n.s. p¼0.02*
Need for social
support
P 12.9 (5.6) 15.4 (5.3) 11.3 (5.2) p<0.001y
C 13.5 (5.7) 14.9 (5.3) 12.7 (5.3) n.s.
n.s. n.s. n.s.
Avoidance
tendency
P 13.5 (5.1) 14.4 (4.7) 12.9 (5.3) n.s.
C 11.3 (5.3) 12.8 (5.3) 9.9 (5.0) n.s.
p¼0.008* n.s. p¼0.010*
Flight tendency P 10.6 (4.7) 11.4 (4.8) 10.1 (4.6) n.s.
C 9.4 (4.2) 10.8 (4.6) 8.4 (3.6) p¼0.001y
n.s. n.s. p¼0.006*
Social
withdrawal
P 7.6 (5.3) 7.8 (5.1) 7.4 (5.4) n.s.
C 5.5 (4.3) 6.5 (4.3) 5.4 (4.7) n.s.
p¼0.009* n.s. p¼0.009*
Rumination/
pensiveness
P 15.0 (5.7) 16.4 (5.1) 14.1 (5.9) n.s.
C 12.0 (5.5) 13.7 (5.8) 10.0 (5.1) n.s.
p¼0.002* p¼0.020* p¼0.003*
Resignation P 7.3 (5.2) 8.3 (5.3) 6.6 (5.1) n.s.
C 5.7 (4.6) 7.3 (5.0) 4.6 (3.3) n.s.
n.s. n.s. p¼0.010*
Self-pity P 8.9 (5.6) 10.1 (5.8) 8.2 (5.4) n.s.
C 7.6 (4.7) 9.1 (4.8) 6.5 (4.0) n.s.
n.s. n.s. p¼0.063*
Self-accusation P 9.0 (4.8) 9.6 (5.6) 8.6 (4.3) n.s
C 7.7 (4.4) 9.0 (4.5) 6.8 (4.7) n.s
n.s n.s p¼0.016*
Aggression P 8.8 (5.5) 8.6 (4.9) 9.0 (5.9) n.s
C 7.9 (4.7) 8.8 (4.4) 7.0 (4.6) n.s
n.s n.s p¼0.084*
Use of self-
medication
P 2.2 (3.3) 2.0 (2.5) 2.3 (3.7) n.s
C 2.9 (3.9) 3.7 (4.2) 3.2 (3.9) n.s
n.s p¼0.005* n.s
Continued
Table 2 Continued
Patients (P)
vs controls (C) Total Women Men
p Value
for gender
differences
Negative coping
style
P 9.7 (4.2) 10.6 (4.2) 9.1 (4.1) p¼0.027y
C 7.9 (3.9) 9.3 (4.0) 7.3 (3.5) p¼0.008y
p¼0.005* n.s. p¼0.002*
P, patients; C, controls; n.s., not significant.
Data are given as means; SD is given in parentheses.
Test items/subscales in which no statistical significances were found are not displayed.
*Significance between patients and control group at p<0.05.
ySignificant gender-specific differences after BonferronieHolm correction.
Figure 1 Results of the Beck Depression Inventory (BDI). The BDI sum
score was slightly higher in female (9.567.6) than in male B27-AU
patients (8.466.7, p¼0.34). Both gender groups reached scores
significantly higher than those of healthy controls (women 4.564.0,
p¼0.004; men 4.164.7, p¼0.002).
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the diversity of evaluation instruments (such as personal inter-
views versus questionnaires) may have led to these diverse
results, which are difﬁcult to compare. To overcome the limi-
tations of previous studies we concentrated on a well-deﬁned
and homogenous uveitis entity and used only standardised
questionnaires.
One aim of our study was to evaluate the patients’ subjective
impression of life events and psychological distress as a trigger
for recurrences of B27-AU. In our study population, 57.9% of the
patients reported life events and psychological distress as
a potential triggers. Theories that distress might negatively
inﬂuence the immune system via the neuro-endocrine system
could be an explanation for a connection between distress and
disease exacerbation, but have not been investigated closely
enough to draw deﬁnite conclusions.21 Distress might play a role
before an attack of B27-AU, but deﬁnitely plays a role in the
time after. Future studies will have to investigate both topics, as
too many interactions still remain unclear.
Furthermore, the presence of depressive symptoms, disease
and stress-coping strategies were analysed using standardised
and validated questionnaires. A special focus was set on
analysing gender-speciﬁc differences. The male:female ratio of
1.7:1 is comparable to the ﬁndings of previous studies on B27-
AU patients.22 Test results indicating the presence of depressive
moods were found in 31.6% of patients. These results support
the data reported by Carrim et al, according to whom patients
with acute AU experience an extraordinary burden in terms of
their psychological well-being and general health (table 4).14
The patients investigated in that study achieved higher (ie,
poorer) scores on the General Health Questionnaire than did
controls. The General Health Questionnaire is a psychometric
instrument measuring stress, social dysfunction and depres-
sion, and is therefore comparable with the BDI used in our
study.
With regard to disease coping, we found speciﬁc behaviour
patterns attributable to both sexes (‘cognitive avoidance’), but
also gender-speciﬁc ones. Franke et al, who studied psychoso-
matic aspects of 51 patients with various forms of uveitis in
a pilot study, concluded that uveitis patients apply speciﬁc
coping strategies, have a lower disease-speciﬁc quality of life
and suffer from greater psychological distress (table 4).4 Our
results thus provide another informative basis concerning B27-
AU patients.
Concerning gender-speciﬁc differences, women appear to
suffer more from the psychological strain caused by B27-AU
than men, which is demonstrated by speciﬁc behaviour patterns.
In comparison with men, women exhibited a tendency towards
depressive moods, with a strong bodily component as reﬂected
in increased ‘loss of libido’. A possible explanation for these results
could be the knowledge that women are more sensitive to pain
than men. In diseases associated with chronic pain women
achieve higher scores concerning depression and dejection.23
Behavioural patterns during stressful situations also differed
between genders (SCI), although ﬁndings in women were not as
noticeable as in men. Male B27-AU patients exhibited predom-
inantly negative coping strategies. This underlines the impor-
tance of differentiating between female and male patients in
order to be able to offer a gender-tailored supportive approach.
As a probable limitation of the study the participation rate of
45% has to be discussed. According to various authors the
response rates to postal surveys rarely exceed 50% 24 25, especially
if no factors apply that are known to increase compliance (short
questionnaires, complex follow-up procedures such as telephone
contacts or re-sending the questionnaire or offering a monetary
incentive).24 26 None of the latter factors were used in our study,
thus explaining the response rate achieved. Other problems in
studies using questionnaires are those of social desirability bias
and concealment of sensitive information. Besides the fact that
these apply rather to personal or telephone interviews than to
postal surveys, care was taken to compose an invitation letter
without suggestive questions. We therefore believe that patients
suffering from more versus fewer symptoms were addressed
equally and our results are not biased in that way.
Figure 2 Numbers of HLA-B27-associated anterior uveitis (B27-AU)
patients stating psychological distress with or without specific life
events preceding an acute attack. Of 171 B27-AU patients, 99 (57.9%)
stated that they had felt psychological distress before acute relapses,
23.4% distress only, and 34.5% distress and specific life events. Women
reported a connection more often than men (p¼0.045). Distributions
within gender group are given in percentages (equal total).
Table 3 HLA-B27-associated anterior uveitis (B27-AU) patients’
subjective estimations about psychological distress or life events as
triggers for relapses
Total patient
population Women Men
Patients reporting of distress with or without
life event(s) before an B27-AU attack
57.9 (99) 64.1 (41)* 54.2 (58)
Patients stating distress only 23.4 (40) 29.7 (19) 19.6 (21)
Patients stating distress and specific life
events
34.5 (59) 34.4 (22) 34.6 (37)
Life events (10 most often stated, in quantitative order)
Death in family 18.1 (31) 21.9 (14) 15.9 (17)
Separation 15.2 (26) 14.1 (9) 15.9 (17)
Common cold 11.7 (20) 15.6 (10) 9.3 (10)
Redundancy 10.5 (18) 9.4 (6) 11.2 (12)
Occupational change 8.8 (15) 7.8 (5) 9.3 (10)
Divorce 8.8 (15) 10.9 (7) 7.5 (8)
Diagnosis of an illness 8.2 (14) 7.8 (5) 8.4 (9)
Accident 7.0 (12) 6.3 (4) 7.5 (8)
Moving house 6.4 (11) 9.4 (6) 4.7 (5)
Birth of a child 2.3 (4) 4.7 (3) 0.9 (1)
Data are given as percentage relating to group (total of patients or gender); number of
patients per gender group is given in parentheses.
*Significance at p<0.05.
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In conclusion, the results of our study indicate that patients
with a history of B27-AU are at risk of suffering from depression
and tend to use negative coping strategies. According to gender,
patients are at risk of encountering speciﬁc and sustained
psychological problems. A signiﬁcant proportion of patients
believed in psychological distress or life events as a potential
trigger for recurrences. These results show that the management
of uveitis patients should encompass not only standardised
treatment strategies of the ocular disease itself, but also clear
information about the relapsing nature of B27-AU, the potential
role of distress or life events as triggers, and the disease’s impact
on psychological well-being. In addition, whenever possible
a behaviour therapy focused on cognitive styles should be
proposed, to support the patients’ effort and success in dealing
with the disease. Through identiﬁcation of situations causing
personal distress, patients can learn to either ‘ﬁght’ or ‘ﬂight’ in
speciﬁc situations, depending upon individual coping patterns.
To recognise the body’s tendency towards highly charged states
in distress situations, and to alter behaviour accordingly, can
reduce the length of time a person suffers from distress, and
reduce the body’s continued need to produce epinephrine to
cope with danger that does not really exist. Improving coping
mechanisms in the therapeutic sense can involve meditation,
Jacobson’s progressive muscle relaxation, cognitive behavioural
therapy and recognition of the body’s inappropriate response to
distress (eg, biofeedback).
Our ﬁndings conﬁrm the need for an interdisciplinary
and gender-tailored management of B27-AU that combines
conventional treatment of uveitis with psychological counselling
or guidance.
Funding This work has been partly supported by Kampf der Blindheit (Association for
Prevention of Blindness) in Vienna. The sponsor was not involved in the design or
conduct of the research project.
Competing interests None declared.
Patient consent Obtained.
Ethics approval This study was conducted with the approval of the Ethics
Committee of the Medical University Vienna Borschkegasse 8b/6 A-1090 Vienna
Austria and in accordance with the Declaration of Helsinki.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Power WJ, Rodriguez A, Pedroza-Seres M, et al. Outcomes in anterior uveitis
associated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646e51.
2. Stoltz CM, Baime MJ, Yaffe K. Depression in the patient with rheumatologic
disease. Rheum Dis Clin North Am 1999;25:687e702.
3. Barlow JH, Macey SJ, Struthers GR. Gender, depression, and ankylosing
spondylitis. Arthritis Care Res 1993;6:45e51.
4. Franke GH, Schutte E, Heiligenhaus A. Rehabilitation e psychological aspects of
uveitis. Psychother Psychosom Med Psychol 2005;55:65e71.
5. Schlaegel TF Jr, Levitt EE. Psychopathology in adults with uveitis. Am J Ophthalmol
1959;48:312e16.
6. Erbaugh JK, Fajardo RV. Emotional factors in uveitis: a pilot study. Surv Ophthalmol
1962;7:199e204.
Table 4 Previous studies on the psychopathology of uveitis
Authors Year
Questionnaires
used (author)
Number
of uveitis
patients
Uveitis type,
number of patients Results
Schlaegel and Levitt5 1959 Minnesota Multiphasic
Personality Inventory
49 AU, AU+PU; granulomatous
versus non-granulomatous;
severity staging
Significantly higher values of psychopathology in uveitis
patients; the location, type and severity of uveitis or sex
are not correlated with psycho-pathology.
Erbaugh and Fajardo6 1962 Personal interview 71 No details given Uveitis patients report more depressive episodes prior to
hospitalisation than controls.
Heaton7 1964 Personal interview 224 AU (n¼157) Three potential triggers of the disease: (1) maladaptation to
the social environment may act as a predisposing factor
because 21% of patients mentioned interpersonal stress
8 weeks before uveitis; (2) influenza in 6.2%; (3) common
cold in 3.6%.
PU (n¼ 20)
Pan (n¼ 47)
Sen8 1971 Personal interview 48 AU (n¼36) Stress was reported as a factor influencing the
development or progression of uveitis by 37.5% of patients
(16.6% reported stress in interpersonal relationships).
PU (n¼5)
Pan (n¼7)
Kumar9 1981 Modified Life Inventory Scale 40 Patients with controlled uveitis Correlation between elevated stress scores and uveitis.
Secchi et al10 1987 Paykel Scale For Life Events
(Paykel), Symptom Distress
Checklist (Derogatis)
60 RAAU, (n¼60; active n¼15,
quiescent n¼45)
No difference between the uveitis group and a reference
group concerning life events or psychological distress.
Mayer et al11 1994 Life Change Scale (Rahe) 21 AU (n¼14) Subjective importance of the patients’ professional life on
their flare-ups; psychological and social factors were
perceived as triggers.
IU (n¼3)
PU (n¼4)
Mulholland et al12 2000 Holmes and Rahe’s Social
Readjustment Scale (Rahe),
Spielberger State-Trait Anxiety
Inventory (Spielberger)
35 Idiopathic RAAU (n¼35) Stress was not involved in triggering recurrences.
Schiffman et al13 2001 SF-36 Health survey (Ware),
NEI VFQ-25 (Mangione)
76 AAU (n¼13) Scores significantly lower than those of the general US
population; the severity of uveitis is correlated with a drop
in scores.
IU (n¼17)
PU (n¼26)
Pan (n¼20)
Franke et al4 2004 Schedule of Recent Experiences
(Holmes), Stress Coping Questionnaire
(Janke) Essen Coping Questionnaire
(Franke), Brief Symptom Inventory
(Derougatis), NEI VFQ (Mangione)
51 Chronic uveitis (n¼51) Patients with uveitis: more numerous recent life events,
poorer coping strategies, greater psychological distress,
poorer quality of life. At follow-up patients with recurrence
of uveitis had poorer values than did those without
recurrence.
Carrim et al14 2006 General Health Questionnaire
(Goldberg), Social Readjustment
Rating Questionnaire (Holmes)
42 AAU (n¼42) Relationship between stress and recurrence of AAU; poor
general health during flare-up.
AAU, acute anterior uveitis; AU, anterior uveitis; IU, intermediate uveitis; NEI VFQ, National Eye Institute visual functioning questionnaire; PU, posterior uveitis; Pan, panuveitis; RAAU, recurrent
acute anterior uveitis.
Br J Ophthalmol 2011;95:699e704. doi:10.1136/bjo.2009.174839 703
Clinical science
 o
n
 30 January 2019 by guest. Protected by copyright.
http://bjo.bmj.com/
Br J O
phthalm
ol: first published as 10.1136/bjo.2009.174839 on 22 October 2010. Downloaded from 
7. Heaton JM. An ecologic approach to uveitis. Am J Ophthalmol 1964;57:
122e8.
8. Sen DK. Endogenous uveitis in relation to stressda clinical study. Eye Ear Nose
Throat Mon 1971;50:108e10.
9. Kumar A, Nema HV, Thakur V. Stress and uveitis. Ann Ophthalmol
1981;13:1077e80.
10. Secchi AG, Magni G, Tognon MS, et al. A psychosomatic approach to idiopathic
recurrences of anterior uveitis. Am J Ophthalmol 1987;104:174e8.
11. Mayer H, Kraus-Mackiw E, Arocker-Mettinger E, et al. Psychosomatic
aspects of uveitis in the context of working life. In: Nussenblatt RB, Whitcup SM,
Caspi RR, et al, eds. Advances in ocular immunology. Amsterdam: Elsevier Science,
1994:349e52.
12. Mulholland B, Marks M, Lightman SL. Anterior uveitis and its relation to stress.
Br J Ophthalmol 2000;84:1121e4.
13. Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health
status in patients with uveitis. Arch Ophthalmol 2001;119:841e9.
14. Carrim ZI, Ahmed TY, Taguri AH. The relationship between stress and acute anterior
uveitis. Acta Ophthalmol Scand 2006;84:795e8.
15. Mohr DC, Hart SL, Julian L, et al. Association between stressful life events and
exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328:731.
16. Karlidag R, Unal S, Evereklioglu C, et al. Stressful life events, anxiety, depression
and coping mechanisms in patients with Behcet’s disease. J Eur Acad Dermatol
Venereol 2003;17:670e5.
17. Beck AT, Hautzinger M, Bailer M, et al. Beck depression inventory. Bern: Hans Huber
Verlag, 1995.
18. Muthny FA. Freiburger fragebogen zur krankheitsverarbeitung. Weinheim: Beltz Test
GmbH, 1989.
19. Jahnke W, Erdmann G. Stressverarbeitungsfragebogen 120. Goettingen: Hogrefe
Verlag, 1997.
20. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat
1979;6:65e70.
21. O’Connor GR. Factors related to the initiation and recurrence of uveitis. XL Edward
Jackson memorial lecture. Am J Ophthalmol 1983;96:577e99.
22. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated
systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 1996;121:47e56.
23. Schiesser AW, Katzenschlager S, Benetka G. Multimodel treatment of chronified,
non malignant pain and its influence on pain behavior, social and psychological
aspects. In: Hu F, ed, Pain research progress: migraine, fibromyalgia and related pain.
Hauppauge, NY: Nova Science Publishers, 2008:151e74.
24. Nakash RA, Hutton JL, Jorstad-Stein EC, et al. Maximising response to postal
questionnairesda systematic review of randomised trials in health research. BMC
Med Res Methodol 2006;6:5.
25. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published
in medical journals. J Clin Epidemiol 1997;50:1129e36.
26. Edwards P, Roberts I, Clarke M, et al. Methods to increase response rates to postal
questionnaires. Cochrane Database Syst Rev 2007;(2):MR000008.
The BMJ Group is delighted to announce 
the launch of BMJ Open, a new and exciting open 
access online journal of medical research.
BMJ Open publishes the full range of research articles 
from protocols and phase I trials to meta analyses.
Accessible to everyone
• Fully open transparent peer review
• Open access means maximum exposure for all articles
• Article-level metrics showing use and impact
• Rate and comment on articles
For more details visit 
bmjopen.bmj.com
SUBMIT
NOW
704 Br J Ophthalmol 2011;95:699e704. doi:10.1136/bjo.2009.174839
Clinical science
 o
n
 30 January 2019 by guest. Protected by copyright.
http://bjo.bmj.com/
Br J O
phthalm
ol: first published as 10.1136/bjo.2009.174839 on 22 October 2010. Downloaded from 
